Dominican Republic Cosmetics and Personal Care Manufacturing 2026

The Dominican Republic’s cosmetics and personal care manufacturing sector produces a broad range of products for domestic consumption and U.S. export: skin care formulations, hair care products, color cosmetics, sun care preparations, and OTC drug-cosmetic combination products (“cosmeceuticals”). DR manufacturers leverage natural Caribbean-origin ingredients — aloe vera, coconut derivatives, cacao butter, sugar cane humectants — to serve U.S. natural beauty market demand, with CAFTA-DR duty-free access providing cost advantages versus Chinese-origin cosmetics.

FDA Cosmetic Compliance Framework

The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) significantly expanded FDA’s cosmetic regulatory authority, requiring: facility registration (by December 2023 for large manufacturers, December 2024 for small businesses); product listing submission; Good Manufacturing Practice (GMP) compliance (FDA final rule under development, ISO 22716 likely baseline); serious adverse event reporting; and fragrance allergen disclosure. DR cosmetics manufacturers exporting to the United States must comply with MoCRA facility registration and product listing requirements regardless of manufacturing location.

OTC Drug-Cosmetic Products

Products making drug claims — sunscreens (SPF), anti-dandruff shampoos, antiperspirants, acne treatments (benzoyl peroxide, salicylic acid), whitening toothpaste — are regulated as OTC drugs under FDA 21 CFR Parts 330–358 OTC Drug Monograph system. DR manufacturers producing OTC drug products for U.S. export must operate under FDA Drug GMP (21 CFR Part 211) and list as drug establishment registrants. DIGEMAPS drug manufacturing facility licenses and FDA OTC drug establishment registration are both required for DR manufacturers targeting U.S. OTC drug-cosmetic market segments.

Natural and Organic Cosmetics Manufacturing

DR’s agricultural sector provides natural cosmetic ingredients that support premium positioning in U.S. natural beauty markets: organic aloe vera gel (DR is a significant Caribbean aloe producer); raw and processed cacao butter from DR’s world-class cacao sector; virgin coconut oil from DR Pacific coast production; and specialty botanical extracts from endemic DR flora. COSMOS Organic certification (from Ecocert or BDIH) for DR-manufactured natural cosmetics is achievable through certified organic ingredient sourcing and COSMOS-compliant manufacturing processes.

Section 301 Tariff Context

Chinese-origin cosmetics and personal care products face Section 301 tariffs of 7.5–25% across HS Chapter 33 categories (perfumes, cosmetics, preparations). DR-manufactured cosmetics under CAFTA-DR enter the U.S. at 0% import duty. The duty differential creates a 7.5–25% landed cost advantage for DR-manufactured cosmetics versus Chinese-origin equivalents, enabling DR manufacturers to price competitively for U.S. private label and OEM cosmetics programs.

Free Zone Manufacturing Advantages

Cosmetics manufacturers in DR CNZFE-certified free zones benefit from Law 8-90’s complete tax package: 0% corporate income tax, 0% import duties on raw materials (active ingredients, fragrances, packaging components), and 0% export duties on finished cosmetic products. ISO 22716 (Cosmetics GMP) certified DR facilities can achieve cosmetic ingredient and product registration in both U.S. and EU markets, supporting multi-market export programs from a single DR manufacturing base.

EGS Cosmetics Manufacturing Assessment

Esco Global Strategies evaluates cosmetics and personal care manufacturing opportunities in DR for brands, contract manufacturers, and OEM suppliers seeking Caribbean-origin production with CAFTA-DR duty-free U.S. market access. Complete the EGS qualification assessment to explore DR cosmetics manufacturing for your brand portfolio.

Explore More: EGS Insights Hub | DR Manufacturing Sectors | Contact Our Team